Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15551721)

Published in Cutis on October 01, 2004

Authors

Jean Paul Ortonne1, Francisco Camacho, Nicholas Wainwright, Louise Bergfelt, Wiete Westerhof, Diane Roseeuw

Author Affiliations

1: Hôpital de l'Archet, Service de Dermatologie, Rte Saint Antoine de Ginestière 151, 06002 Nice Cedex 03, France. ortonne@unice.fr

Articles citing this

Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma. J Clin Aesthet Dermatol (2016) 0.75

Articles by these authors

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Sense of coherence and mortality in men and women in the EPIC-Norfolk United Kingdom prospective cohort study. Am J Epidemiol (2003) 2.26

Hypnotherapeutic management of alopecia areata. J Am Acad Dermatol (2006) 1.62

Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol (2005) 1.51

Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. J Invest Dermatol (2007) 1.48

Noninvasive techniques for the evaluation of skin color. J Am Acad Dermatol (2006) 1.43

Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest (2003) 1.41

UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol (2005) 1.40

Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol (2006) 1.08

Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes. J Invest Dermatol (2009) 1.03

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety. Cell Tissue Bank (2011) 1.02

Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol (2003) 0.99

Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol (2008) 0.98

Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. J Am Acad Dermatol (2006) 0.97

Pigmented and reticulated plaques of folds. A case of lichen planus pigmentosus-inversus? Eur J Dermatol (2002) 0.97

Progressive macular hypomelanosis: an overview. Am J Clin Dermatol (2007) 0.94

Long-term involution of unilateral porokeratotic eccrine ostial and dermal duct naevus. Acta Derm Venereol (2003) 0.92

Alexithymia and dermatology: the state of the art. Int J Dermatol (2008) 0.91

Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res (2004) 0.88

Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation. Exp Dermatol (2012) 0.86

A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem Res Toxicol (2009) 0.86

Increased history of childhood and lifetime traumatic events among adults with alopecia areata. J Am Acad Dermatol (2008) 0.85

Hypnosis and alopecia areata: Long-term beneficial effects on psychological well-being. Acta Derm Venereol (2011) 0.83

The "caveolae brake hypothesis" and the epidermal barrier. J Invest Dermatol (2008) 0.83

Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83

Adverse experience in childhood as a developmental risk factor for altered immune status in adulthood. Int J Behav Med (2003) 0.83

Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. J Pathol (2002) 0.81

Effect of household processing and unit-to-unit variability of pyrifenox, pyridaben, and tralomethrin residues in tomatoes. J Agric Food Chem (2005) 0.80

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi. Cell Tissue Bank (2011) 0.80

Letter: Stump hyperhidrosis in a leg amputee: treatment with botulinum toxin A. Dermatol Surg (2007) 0.79

Progressive macular hypomelanosis is associated with a putative Propionibacterium species. J Invest Dermatol (2009) 0.79

Elephantiasis nostras verrucosa treated with surgical débridement. Dermatol Surg (2005) 0.79

Hypnosis in refractory alopecia areata significantly improves depression, anxiety, and life quality but not hair regrowth. J Am Acad Dermatol (2010) 0.79

Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed (2008) 0.79

[Effectiveness of antimicrobial formulations for acne based on orange (Citrus sinensis) and sweet basil (Ocimum basilicum L) essential oils]. Biomedica (2012) 0.78

Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol (2005) 0.78

Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation. J Dermatol Sci (2010) 0.78

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation. Cell Tissue Bank (2010) 0.78

Sunscreen use and skin protection behaviour on the Belgian beach: a comparison 9 years later. Eur J Cancer Prev (2012) 0.78

Association of depression with peripheral leukocyte counts in EPIC-Norfolk--role of sex and cigarette smoking. J Psychosom Res (2003) 0.78

Analysis and residue levels of forchlorfenuron (CPPU) in watermelons. J Environ Sci Health B (2007) 0.78

Analysis of forchlorfenuron in vegetables by LC/TOF-MS after extraction with the buffered QuEChERS method. J Agric Food Chem (2010) 0.77

Evaluation of biophysical and clinical parameters of skin barrier function among hospital workers. Contact Dermatitis (2002) 0.77

Assessing supercritical fluid extraction for the analysis of fipronil, kresoxim-methyl, acrinathrin, and pyridaben residues in melon. J Environ Sci Health B (2007) 0.77

Effect of rice starch as a bath additive on the barrier function of healthy but SLS-damaged skin and skin of atopic patients. Acta Derm Venereol (2002) 0.76

[Evaluation of a screening system for patients with pigmented lesions using store-and-forward teleconsultation]. Actas Dermosifiliogr (2005) 0.76

Occupational alopecia or alopecia areata? J Am Acad Dermatol (2002) 0.75

Comment on the letter by Chung et al. about progressive macular hypomelanosis. J Eur Acad Dermatol Venereol (2008) 0.75

Behavioral characterization of non-copulating male rats with high spontaneous yawning frequency rate. Behav Brain Res (2010) 0.75

[Nonvenereal sclerosing lymphangitis of the penis: presentation of a clinical case]. Actas Dermosifiliogr (2006) 0.75

The effect of H₁ and H₂ receptor antagonists on melanogenesis. Indian J Dermatol Venereol Leprol (2011) 0.75

Disseminated cutaneous B-cell lymphoma mimicking pseudolymphoma over a period of six years. Am J Dermatopathol (2004) 0.75

[Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus]. Actas Dermosifiliogr (2005) 0.75

Multiple cutaneous granular cell tumors in a child in remission for Hodgkin's disease. J Am Acad Dermatol (2002) 0.75

Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three cases. Melanoma Res (2009) 0.75

Effect of genetic and phenotypic factors on the composition of commercial marmande type tomatoes studied through HRMAS NMR spectroscopy. Food Chem (2013) 0.75

The effect of two moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol (2002) 0.75

Clinical scoring and biophysical evaluation of nasolabial skin barrier damage caused by rhinorrhea. Contact Dermatitis (2008) 0.75

[Cutaneous bronchogenic cyst]. Actas Dermosifiliogr (2005) 0.75

Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience. J Cosmet Dermatol (2005) 0.75

[Pyoderma gangrenosum over a saphenectomy scar in a cANCA-positive patient with diverticulitis]. Actas Dermosifiliogr (2005) 0.75

Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol. Acta Derm Venereol (2003) 0.75